Segmentectomy effective option for lung cancer patients with low muscle mass: Study
A new study published in the Annals of Surgical Oncology revealed that individuals with little muscle mass, segmentectomy should be actively taken into account due to its less invasive nature.
Peripheral small-size lung cancer is increasingly treated by sublobar resection. Because segmentectomy is less intrusive than lobectomy and provides greater local control than wedge resections, it has emerged as a viable therapeutic choice among sublobar resection procedures. Segmentectomy outperformed lobectomy in terms of overall survival (OS) for patients with small-size non-small cell lung cancer (NSCLC), according to a large prospective randomized study.
The fact that segmentectomy is less intrusive than lobectomy may be one explanation for this finding. Low muscle mass, or sarcopenia, is now well acknowledged as a risk factor for a worse prognosis in a variety of benign and malignant diseases. In several cancer types, preoperative sarcopenia has been linked to postoperative prognoses.
Little is known about how segmentectomy and lobectomy affect the postoperative results of patients with low muscle mass, despite the fact that segmentectomy is less intrusive than lobectomy. The postoperative prognosis of patients with non-small cell lung cancer was investigated in this study based on the kind of surgery and preoperative muscle mass.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.